Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Arcturus Therapeutics Holdings Inc. shareholders approved To elect Dr. Peter Farrell, Joseph E. Payne, Andy Sassine, James Barlow, Dr. Edward W. Holmes, Dr. Magda Marquet, Dr. Jing L. Marantz and Dr. John H. Markels to the Board of Directors at the 2023-06-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
(1) To elect Dr. Peter Farrell, Joseph E. Payne, Andy Sassine, James Barlow, Dr. Edward W. Holmes, Dr. Magda Marquet, Dr. Jing L. Marantz and Dr. John H. Markels to the Board of Directors
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Arcturus Therapeutics Holdings Inc. shareholders approved To approve, on a non-binding advisory basis, the resolution approving named executive officer compensation (say-on-pay) at the 2023-06-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement: 11,959,501 4,562,055 15,403 2,450,043
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Arcturus Therapeutics Holdings Inc. shareholders approved To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
Approval of the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023, as provided in Proposal Number 3 of the Proxy Statement: 18,955,484 22,224 9,294 N/A
View on SEC.gov